IGC Pharma
29 hedge funds and large institutions have $6.07M invested in IGC Pharma in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% less capital invested
Capital invested by funds: $7.9M → $6.07M (-$1.83M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
29
Holding in Top 10
–
Calls
$359K
Puts
$277K
Top Buyers
| 1 | +$1.23M | |
| 2 | +$161K | |
| 3 | +$21.9K | |
| 4 |
BlackRock
New York
|
+$18.5K |
| 5 |
Jane Street
New York
|
+$14K |
Top Sellers
| 1 | -$646K | |
| 2 | -$39.2K | |
| 3 | -$31K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$29K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$19K |